Vella Bioscience produces Pleasure Serum, a clinically demonstrated pre-play topical serum that promotes increased arousal, lubrication and intense orgasms. The company uses a proprietary nano-encapsulated CBD technology designed to deliver CBD beyond the skin to relax vaginal and clitoral smooth muscle and encourage arousal and orgasm. Leadership includes CEO Nial DeMena and COO Carolyn Wheeler, and the company was co-founded by Dr. Harin Padma-Nathan, the lead principal investigator for Viagra® and Cialis®. Vella intends to use new funding to advance a product portfolio of science-driven innovations and strengthen sexual empowerment for women. The company is based in Los Angeles, CA. Financially, Vella closed a Seed II round of $7M at just over a $50M post-money valuation.

Total raised

$7M

Funding rounds

1

Latest round

Seed

Latest activity

May 2021